![]() |
![]() |
Your cart is empty |
||
Books > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology
This groundbreaking text takes current knowledge of the basal ganglia far from well-known motor-based models to a more inclusive understanding of deep-brain structure and function. Synthesizing diverse perspectives from across the brain-behavioral sciences, it tours the neuroanatomy and circuitry of the basal ganglia, linking their organization to their controlling functions in core cognitive, behavioral, and motor areas, both normative and disordered. Interactions between the basal ganglia and major structures of the brain are identified in their contributions to a diverse range of processes, from language processing to decision-making, emotion to visual perception, motivation to intent. And the basal ganglia are intimately involved in the mechanisms of dysfunction, as evinced by chapters on dyskinesia, Parkinson's disease, neuropsychiatric conditions, and addictions. Included in the coverage: Limbic-basal ganglia circuits: parallel and integrative aspects. Dopamine and its actions in the basal ganglia system. Cerebellar-basal ganglia interactions. The basal ganglia contribution to controlled and automatic processing. The basal ganglia and decision making in neuropsychiatric disorders. The circuitry underlying the reinstatement of cocaine seeking: modulation by deep brain stimulation. The basal ganglia and hierarchical control in voluntary behavior. Its breadth and depth of scholarship and data should make The Basal Ganglia a work of great interest to cognitive psychologists and neuroscientists, neuropsychologists, neurologists, neuropsychiatrists, and speech-language pathologists.
Dr. Elisabeth Bock (Photo Keenpress) This book contains review articles that produce a snapshot of recent developments in the field of the neural cell adhesion molecule NCAM. The chapters are grouped into sections reflecting various aspects of NCAM structure and function. The themes cover the structural basis of cell adhesion mediated by NCAM and NCAM interaction partners, NCAM-mediated signaling determinants of NCAM function under physiological conditions and in disease, and the therapeutic potential of NCAM mimetics. Section 1, "Structure and Ligands of NCAM," introduces the reader to the str- tural basis of NCAM-mediated cell adhesion, discussing the current knowledge of extracellular and intracellular NCAM ligands and the structural basis of NCAM int- actions with the fibroblast growth factor (FGF) receptor. Section 2, "NCAM and Polysialic Acid," focuses on NCAM polysialylation, discussing the structural and functional aspects of the most important posttranslational modifications of NCAM by the addition of a long linear homopolymer of sialic acid to the fifth Ig-like NCAM module. Section 3, "NCAM-mediated Signal Transduction," is devoted to signal v BookID 187530_ChapID FM1_Proof# 1 - 01/03/2011 BookID 187530_ChapID FM1_Proof# 1 - 01/03/2011 vi Preface transduction mechanisms associated with NCAM-mediated adhesion, with a focus on signaling pathways involved in NCAM-mediated neurite outgrowth, the role of growth-associated proteins, signaling through lipid microdomains, and signaling crosstalk with the epidermal growth factor (EGF) receptor. Section 4, "NCAM Metabolism," focuses on current knowledge about NCAM biosynthesis and the g- eration and role of soluble NCAM.
Although speech is the primary behavioral medium by which humans communicate, its auditory basis is poorly understood, having profound implications on efforts to ameliorate the behavioral consequences of hearing impairment and on the development of robust algorithms for computer speech recognition. In this volume, the authors provide an up-to-date synthesis of recent research in the area of speech processing in the auditory system, bringing together a diverse range of scientists to present the subject from an interdisciplinary perspective. Of particular concern is the ability to understand speech in uncertain, potentially adverse acoustic environments, currently the bane of both hearing aid and speech recognition technology. There is increasing evidence that the perceptual stability characteristic of speech understanding is due, at least in part, to elegant transformations of the acoustic signal performed by auditory mechanisms. As a comprehensive review of speech's auditory basis, this book will interest physiologists, anatomists, psychologists, phoneticians, computer scientists, biomedical and electrical engineers, and clinicians.
As autism is associated with many rare diseases, this extensive bench book examines how no one single model can be used; multiple organism models are needed, each one corresponding to one of the diseases or to one aspect of a disease. Split into five sections, Organism Models of Autism Spectrum Disorders explores selecting the good species for the specific disease, modeling autism spectrum disorders (ASD) at the brain level, studying communication and social interactions, using vertebrates or invertebrate models of ASD as defined by DSM-5R, as well as pursuing models of diseases associated with an increased incidence of ASDs. Written for the respected Neuromethods series, this detailed volume contains the kind of insight and useful, practical advice that ensures more successful results in the lab. Comprehensive and handy, Organism Models of Autism Spectrum Disorders will benefit psychiatrists and geneticists, as well as behavioral researchers who, realizing how important it is to improve their knowledge through more molecular approaches, are looking for the most suitable organisms.
One of the most striking features of Coordination Dynamics is its interdisciplinary character. The problems we are trying to solve in this field range from behavioral phenomena of interlimb coordination and coordination between stimuli and movements (perception-action tasks) through neural activation patterns that can be observed during these tasks to clinical applications and social behavior. It is not surprising that close collaboration among scientists from different fields as psychology, kinesiology, neurology and even physics are imperative to deal with the enormous difficulties we are facing when we try to understand a system as complex as the human brain. The chapters in this volume are not simply write-ups of the lectures given by the experts at the meeting but are written in a way that they give sufficient introductory information to be comprehensible and useful for all interested scientists and students.
This handbook provides a comprehensive review of the numerous factors associated with treatments for children, youth, and adults with autism spectrum disorder (ASD). It offers in-depth analysis of evidence-based treatments for young children, providing coverage on interventions within social skills training, school curricula, communication and speech training, and augmentative communication. It also covers treatments for adolescents and adults, including vocational programs, social integration programs, and mental health resources. Chapters also review several popular interventions such as functional behavior analysis, sensory integration therapy, early intensive behavioral interventions (EIBI), and floor time. In addition, the Handbook discusses standards of practice, focusing on ethical issues, review boards, training concerns, and informed consent. Topics featured in the Handbook include: Training for parents of individuals diagnosed with ASD. Treatment of socially reinforced problem behavior. Comorbid challenging behaviors. Post-secondary education supports and programs for adults. The TEACCH Program for people with ASD. Treatment of addiction in adults with ASD. Diet and nutrition based treatments targeted at children with ASD. The Handbook of Treatments for Autism Spectrum Disorder is a must-have reference for researchers, clinicians/professionals, and graduate students in clinical child, school, and developmental psychology, child and adolescent psychiatry, and social work as well as rehabilitation medicine/therapy, behavioral therapy, pediatrics, and educational psychology.
First published in 1943, Vitamins and Hormones is the
longest-running serial published by Academic Press. In the early
days of the Serial, the subjects of vitamins and hormones were
quite distinct. The Editorial Board now reflects expertise in the
field of hormone action, vitamin action, X-ray crystal structure,
physiology, and enzyme mechanisms. Under the capable and qualified
editorial leadership of Dr. Gerald Litwack, Vitamins and Hormones
continues to publish cutting-edge reviews of interest to
endocrinologists, biochemists, nutritionists, pharmacologists, cell
biologists, and molecular biologists. Others interested in the
structure and function of biologically active molecules like
hormones and vitamins will, as always, turn to this series for
comprehensive reviews by leading contributors to this and related
disciplines.
A compendium of the latest published diagnostic criteria for a diverse group of neurological conditions. The criteria cover a wide spectrum of neurological conditions whose diagnosis does not depend solely on histopathology (e.g., brain tumors), including cerebrovascular diseases, dementias and behavioral disorders, demyelinating disorders, and disorders of consciousness and brain death. Standardized criteria are also provided for epilepsy, genetic syndromes, headache, immune-based disorders, infectious diseases, movement disorders, neuromuscular disorders, and sleep disorders. A dazzling array of tables summarizes useful information on both common and uncommon neurological conditions, including many genetic and pediatric neurological disorders. Innovative and authoritative, Diagnostic Criteria in Neurology begins to do for neurology what the DSM (Diagnostic and Statistical Manual) did for psychiatry.
A panel of international psychiatrists, neurologists, clinical psychologists, and neuropsychiatrists review for the clinical neurologist those aspects of psychiatry that impact the management of neurological disorders. On the one hand, the authors illuminate the neurological aspects of such psychiatric disorders as depression, anxiety disorders, schizophrenia, hysteria, catatonia, addictions, and personality disorders. On the other hand, they also explain in detail the psychiatric evaluation of the neurological patient and discuss the behavioral aspects of the major neurological disorders, including psychiatric complications of dementia and stroke, neuromuscular disorders, the psychiatric aspects of Parkinson's disease, epilepsy, Huntington's disease, Tourette's syndrome, and multiple sclerosis. Comprehensive and timely, Psychiatry for Neurologists helps to close the artificial gap separating neurology and psychiatry so that neurologists feel comfortable managing the psychiatric aspects of the neurological disorders they treat.
This comprehensive, yet practical, text is a ready collection of the most up-to-date information on primary CNS tumors. Authored by a carefully selected group of the world's leading clinicians and scientists, the book is divided into three sections. The opening chapters cover general principles, including epidemiology, pathogenesis, tumor stem cells, supportive care, complications of therapy, and quality of life. The remaining two sections are comprised of treatment-oriented chapters covering the spectrum of gliomas and rarer tumor types. Each of these chapters presents multi-disciplinary therapeutic approaches and addresses specific disease concerns. Throughout, the authors incorporate the cutting-edge advances in molecular biology and genomics that are revolutionizing neuro-oncology. The result is an important clinical resource which provides evidence-based data and interpretation essential to intelligent therapeutic decision making.
The Lost Self: Pathologies of the Brain and Identity is an in-depth exploration of one of the most mysterious and controversial topics in neuroscience, neurology, psychiatry and psychology-namely, the search for the biological basis of the self. The book is a guide to understanding how the brain creates who we are, and what happens when things go wrong. For the first time in a single volume, some of the foremost experts in the fields of philosophy, cognitive neuroscience, neurology, and psychology join together to explore the neurobiology of the self. They first lay the foundation for an understanding of the topic. Then they provide fascinating and detailed accounts of how the self is transformed in patients with brain lesions, autism, and dementia, as well as in drug induced states, during meditation, and while dreaming. Their analysis of these disorders and states is used as a springboard toward a deeper understanding of how a brain creates a self. This fascinating volume will be invaluable to neuroscientists, psychologists, psychiatrists, neurologists, and philosophers of mind, and to their students and trainees.
A hallmark of neurodegenerative proteinopathies is the formation of misfolded protein aggregates that cause cellular toxicity. Though multiple factors like aging, oxidative stress, gene inconsistency, etc. are responsible for the dysfunction of the protein quality control system, targeting protein quality control has become an auspicious approach to block the propagation of neurodegeneration. Quality Control of Cellular Protein in Neurodegenerative Disorders provides diverse aspects exploring the theoretical and practical methods of protein quality control systems and potential therapeutic approaches to halt the development and propagation of neurodegenerative disorders. Featuring coverage on a broad range of topics such as cellular chaperones, protein folding, and stress signaling, this book is ideally designed for neurobiologists, neuropsychologists, neurophysiologists, medical professionals, neuropathologists, researchers, academicians, students, and practitioners engaged in studies of the protein quality control system in neuronal cells.
The past decade has seen an extraordinary growth in research interest in neurotrophic factors, and the study of the neurotrophin family has led this activity. Nevertheless, this area of research has often struggled as a result of techniques that were either inadequate or just emerging from other research fields and disciplines. Neurotrophin Protocols has brought together many leaders in the neurotrophin field who detail their special expertise in a wide variety of techniques. Though most procedures are valid across many diff- ent fields of research, some of those described here have been developed to address particular issues within the neurotrophic factor field. The protocols cover a broad range of biochemical, histological, and biological techniques that are often required by the modern laboratory. However, all have been written with sufficient detail to allow any laboratory to achieve proficiency without need of reference to other texts. Neurotrophin Protocols is divided into four sections dealing with p- tein, RNA, recombinant, and in vivo techniques. Protein techniques have in general been less successfully employed than those dealing with RNA or DNA. However, procedures that achieve localization and quantification of the neurotrophins are now being used more extensively. Their inclusion here should assist further studies at the protein level. Transgenic cell lines and animals are commonplace in the scientific research literature, but their inc- sion in several chapters in this book provide some novel uses that are not readily available elsewhere.
Attention is a key psychological construct in the understanding of human cognition, and the target of enormous efforts to elucidate its physiological mechanisms, as the wealth of literature-both primary and secondary-attests (for recent compilations see Itti, Rees, & Tsotsos, 2005; Paletta & Rome, 2008; Posner, 2004). But in addition to asking what attention actually is, decomposing and analyzing its varieties, or delimiting its neurobiological mechanisms and effects, in this volume we want to explore attention somewhat differently. We believe that a full-fledged theory of attention must consider its workings in the context of motivated, goal-directed, and environmentally constrained organisms. That attention is related to goal-directed behavior is not news. What the contri- tions to this volume do suggest, however, is the existence of fundamental links between attention and two key processes that are crucial for adapted conduct: go- directed behavior and cognitive control. Importantly, they show that these relations can be explored at multiple levels, including neurodynamical, neurochemical, evo- tionary, and clinical aspects, and that in doing so multiple methodological challenges arise that are worth considering and pursuing. The reader will find here, therefore, a selection of contributions that range from basic mechanisms of attention at the n- ronal level to developmental aspects of cognitive control and its impairments. Another trend that will become evident is that, in different ways, the authors stress the need to understand these issues as they unfold in natural behavior (both healthy and pathological), thus arguing for a more ecological approach to these questions.
Cognitive electrophysiology is a very well established field
utilizing new technologies such as bioelectric events-related
potentials (ERP) and magnetic (ERF) recordings to pursue the
investigation of mind and brain. Current research focuses on
reviewing ERP/ERF findings in the areas of attention, language,
memory, visual and auditory perceptual processing, emotions,
development, and neuropsychological clinical damages. The goal of
such research is basically to provide correlations between the
structures of the brain and their complex cognitive functions.
Neurotoxicology is a broad and burgeoning field of research. Its growth in recent years can be related, in part, to increased interest in and concern with the fact that a growing number of anthropogenic agents with neurotoxic potential, including pesticides, lead, mercury, and the polytypic bypro ducts of combustion and industrial production, continue to be spewed into and accumulate in the environment. In addition, there is great interest in natural products, including toxins, as sources of therapeutic agents. Indeed, it is well known that many natural toxins of broadly differing structure, produced or accumulated for predatory or defensive purposes, and toxic agents, accumulated incidentally by numerous species, function to perturb nervous tissue. Components of some of these toxins have been shown to be useful therapeutic agents and/or research reagents. Unfor tunately, the environmental accumulation of some neurotoxic ants of anthropogenic ori gin, especially pesticides and metals, has resulted in incidents of human poisoning, some of epidemic proportion, and high levels of morbidity and mortality. Furthermore, an increasing incidence of neurobehavioral disorders, some with baffling symptoms, is confronting clinicians. It is not clear whether this is merely the result of increased vigi lance and/or improved diagnostics or a consequence of improved health care. In any case, the role of exposure to environmental and occupational neurotoxic ants in the etiology of these phenomena, as well as neurodegenerative diseases, is coming under increasing scrutiny and investigation.
This volume tries to put current therapy - achievements, shortcomings, remaining medical needs - and emerging new targets into the context of increasing knowledge regarding the genetic and neurodevelopmental contributions to the pathophysiology of schizophrenia. Some of the chapters also deal with respective experimental and clinical methodology, biomarkers, and translational aspects of drug development. The volume concentrates on reviewing the ongoing research attempting to identify novel treatments for the cognitive deficits and negative symptoms of schizophrenia, which are not treated adequately by current antipsychotic medications.
Having been a fairly dormant specialty for many decades, in recent years there has been a remarkable increase in activity in Neuro-oncology from basic science through to the clinics. Reflecting this there have been considerable advancements in the understanding of the biology of CNS malignancies which have infirmed the development of many novel and successful therapies. This work aims to bring together the scattered literature on the new concepts in neuro-oncology for the benefit of those in the field. The book moves from concepts in the scientific basis of neuro-oncology, through to modelling techniques and finishing on the translation into clinical practice.
* Includes chapters on sleep phase disorders, sleep apnea, periodic limb movements, narcolepsy, limit setting disorders in children, enuresis, and night terrors.
There are currently no reparative therapies for severe neurological injury, including brain injury, spinal cord injury and stroke. Actually, most treatments are designed simply to limit secondary damage. However, pre-clinical data supports the idea that exogenous stem and progenitor cells have the potential to promote a reparative response to severe neurological injuries. Progenitor Cell Therapy for Neurological Injury is a compilation of seminal essays that explore many unique aspects of neurological injury, focusing on the critical translational issues of cell delivery. Specifically, it discusses routes of administration, types of progenitor cells (alone and/or in combinations), timing of delivery and adjuncts to promote cell engraftment, survival and effectiveness. In addition, many chapters address measuring the effects of transplanted cells and cell tracking. The paradigms of how cell-based therapeutics affect neurological injury is changing rapidly. The developments in this field may ultimately offer realistic hope for improvement in patients with severe injuries. This book is a vital key toward unlocking those future treatments.
A distinguished panel of internationally recognized neuroscientists comprehensively review the involvement of and changes in glial cells both during the normal aging process and in the major disorders of old age. Topics range from the cellular and molecular changes that occur with aging-especially aging-associated activation of astrocytes and microglia and its relation to neuronal injury and repair-to neuron-glia intercommunication. The contributors show how glial signals may be modulated by hormones, growth factors, neurotransmitters, intracellular metabolism, and intercellular exchanges, as well as by aging of the blood-brain barrier.
The therapeutic options for the treatment of multiple sclerosis (MS) and other neurodegenerative and traumatic diseases such as spinal cord injury, Alzheimer's, Parkinson's disease, etc. , have undergone enormous progress over recent years. Despite these encouraging developments, available therapies are only partially effective, and the ultimate goal is still far from being attained. Improved understanding of the cellular and molecular mechanisms of the pathogenesis of neurodegeneration and demyelination has led to a variety of new therapeutic targets and approaches. In addition to modulation of the in?ammatory process (MS) and cl- sical neuroprotection (stroke, AD), therapeutic approaches focussing on active remyelinization and neuronal regeneration have become incre- ingly important. Based on current concepts, this book summarizes new therapeutic approaches. Although it was once thought that the central nervous system (CNS) of mammals was incapable of substantial recovery from injury, it is now clear that the adult CNS remains responsive to various substances that can promote cell survival and stimulate axonal growth. Among these substances are growth factors, including the neurotrophins and cytokines. Stem cell therapies for the induction of remyelinization and neuroregeneration are reviewed. The potential role of a protective - munity in the induction of remyelination and neuroregeneration is also discussed. Different gene therapy approaches for the treatment of MS VI Preface and other neurodegenerative diseases such as Alzheimer's disease and spinal cord injury, etc. , are also summarized.
This book introduces a novel approach for examining language and communication in autism spectrum disorder (ASD) - discourse and conversation analysis. The authors offer a set of very different perspectives on these complex issues than are typically presented in psychological and clinical work. Emerging from a range of social scientific fields, discourse and conversation analysis involve fine-grained qualitative analysis of naturally-occurring, rather than laboratory-based, interaction, enabling broad applications. Presented in two parts, this innovative volume first provides a set of pedagogical chapters to develop the reader's knowledge and skills in using these approaches, before moving to showcase the use of discursive methods through a range of original contributions from world-leading scholars, drawn from a range of disciplines including sociology, academic and clinical psychology, speech and language therapy, critical disability studies and social theory, and medicine and psychiatry. |
![]() ![]() You may like...
Introduction to Basic Aspects of the…
Otto Appenzeller, Guillaume J. Lamotte, …
Hardcover
R3,609
Discovery Miles 36 090
Headache and Migraine in Practice
Mansoureh Togha, Elham Jafari, …
Paperback
R4,083
Discovery Miles 40 830
Artificial Intelligence for Neurological…
Ajith Abraham, Sujata Dash, …
Paperback
R4,069
Discovery Miles 40 690
International Review of Research in…
Robert M. Hodapp, Deborah J. Fidler
Hardcover
R4,671
Discovery Miles 46 710
Imagining the Brain: Episodes in the…
Chiara Ambrosio, William Maclehose
Hardcover
R6,429
Discovery Miles 64 290
Redefining Recovery from Aphasia
Dalia Cahana-Amitay, Martin Albert
Hardcover
R2,942
Discovery Miles 29 420
|